STOCK TITAN

Cochlear Ord Adr Stock Price, News & Analysis

CHEOY OTC

Welcome to our dedicated page for Cochlear Ord Adr news (Ticker: CHEOY), a resource for investors and traders seeking the latest updates and insights on Cochlear Ord Adr stock.

Cochlear Ord Adr (CHEOY) delivers innovative hearing implant solutions through cutting-edge medical technology and patient-centered care. This dedicated news hub provides investors and industry observers with timely updates on corporate developments, financial performance, and advancements in hearing health innovation.

Track all official press releases and market-moving announcements in one centralized location. Key coverage areas include quarterly earnings reports, product innovation milestones, strategic partnerships, and regulatory achievements. Our curated news feed ensures transparent access to operational updates that shape the medical device sector.

Bookmark this page for streamlined monitoring of Cochlear Ord Adr's market position, technological breakthroughs, and healthcare initiatives. Stay informed about developments impacting long-term growth strategies and industry leadership in auditory implant solutions.

Rhea-AI Summary

Cochlear (CHEOY) has been recognized as the most trustworthy healthcare company globally in Newsweek's 2024 World's Most Trustworthy Companies rankings. The assessment, conducted in partnership with Statista, evaluated companies based on customer, investor, and employee trust, gathering 269,000 evaluations from over 70,000 participants.

The global leader in implantable hearing solutions emphasizes customer-centric services through their Connected Care program, which includes rehabilitation programs, collaboration with audiologists, and access to a global community of Cochlear recipients. CEO Dig Howitt highlighted the company's commitment to customer service and support, along with initiatives focused on raising awareness about hearing loss and advocating for improved hearing care access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
Rhea-AI Summary

Cochlear North America has announced eight winners of its 2025 Academic Scholarships on International Cochlear Implant Day. The recipients, all users of Cochlear™ devices, were selected for their leadership, humanity, and academic excellence.

Five students received the Graeme Clark Scholarship, now in its 23rd year: Emily E. (Speech-Language Pathology), Farah B. (Neuroscience), Grace F. (Occupational Therapy), Kaitlin C. (Pre-med), and Sophie G. (Education). Three students were awarded the Anders Tjellström Scholarship, in its 14th year: Dylan G. (Neuroscience/Psychology), Nathaniel G. (Government/Economics), and Zachary M. (Electrical Engineering/MBA).

Each scholarship recipient will receive $2,000 annually for up to four years at an accredited college or university, totaling $8,000 per student. The total scholarship funding for 2025 amounts to $64,000.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Summary

Cochlear, the global leader in implantable hearing solutions, highlights the Crosby family's journey during Healthy Aging Month. Herbert O. Crosby Junior (Butch), a former lineman and Vietnam veteran, experienced severe hearing loss due to prolonged exposure to loud noises. His daughter, Dr. Gina Crosby-Quinatoa, a Speech-Language Pathologist, recognized that her father could benefit from a cochlear implant.

In September 2022, Medicare expanded its coverage criteria for cochlear implants, allowing Butch to qualify for the procedure. He received a Cochlear™ Nucleus® 8 Sound Processor on December 28th, 2022, and was activated on January 23rd, 2023. The implant has significantly improved Butch's quality of life, enabling him to participate in social gatherings and enjoy conversations again.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.27%
Tags
none
-
Rhea-AI Summary

Cochlear, along with members of the Australian Hearing Hub, including National Acoustic Laboratories and Macquarie University, has initiated a groundbreaking collaboration with Google to develop innovative solutions to address hearing loss. This multi-year project will leverage artificial intelligence and machine learning to create personalized hearing devices, targeting environments with complex soundscapes. Additionally, experts have released the first international guidelines for cochlear implant eligibility, aiming to improve screening and referral practices. Currently, only 3 out of 100 adults who could benefit from these implants actually receive them, highlighting the need for better awareness and access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
none
-
Rhea-AI Summary

Cochlear Limited (ASX: COH) announced the winners of its 2023 Graeme Clark, Anders Tjellström, and new Vocational Scholarships, recognizing outstanding leaders in the hearing loss community. The scholarships, totaling $60,000 this year, support students in their academic and vocational pursuits. Recipients include Emily DeMieri, Blessed Mbogo, Gavin Morrobel, and Selena Zou, among others. Cochlear has awarded over $1 million in scholarships since 2002, empowering recipients to reach their career goals. The introduction of the Vocational Scholarship aims to support diverse career paths for Cochlear recipients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
none
Rhea-AI Summary

Cochlear has introduced support for Audio Streaming for Hearing Aids (ASHA) on compatible Fire TV devices, marking a significant step for users of Cochlear hearing implants. This innovation allows direct streaming of audio from Fire TV to Cochlear sound processors, enhancing accessibility for individuals with hearing loss. ASHA support is available for devices such as the Nucleus® 8 and Baha® 6 Max Sound Processors. With over 1.5 billion people affected by hearing loss globally, this development aims to improve the entertainment experience for a substantial audience. This announcement coincides with International Cochlear Implant Day on February 25, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
none

FAQ

What is the current stock price of Cochlear Ord Adr (CHEOY)?

The current stock price of Cochlear Ord Adr (CHEOY) is $88.245 as of May 5, 2025.

What is the market cap of Cochlear Ord Adr (CHEOY)?

The market cap of Cochlear Ord Adr (CHEOY) is approximately 11.2B.
Cochlear Ord Adr

OTC:CHEOY

CHEOY Rankings

CHEOY Stock Data

11.20B
130.79M
0%
Medical Devices
Healthcare
Link
Australia
Sydney